Eyecuracy

Transforming optometry, neurology and ophthalmology care markets through an high-accuracy AI-powered eye tracking solution. Its unique underlying technology provides a far more accurate and cost-effective approach compared to current procedures, thus reducing the burden on patients and healthcare systems. Eyecuracy‘s AI-powered solution is affecting over 20% of the total world population with conditions like binocular vision disorders, mild traumatic brain injury – aka concussion, degenerative brain diseases – like Alzheimer, Parkinson, and ALS, attention deficit hyperactivity disorder, autism syndrome, and many others. These conditions present a huge, strongly underserved multi-billion markets. Current diagnostics procedures for many neurological and ophthalmological conditions rely on subjective assessments, making accurate diagnostics and monitoring difficult. Traditional imaging methods like MRI and CT scans are expensive, timeconsuming, and mostly too coarse to detect most of the conditions. Moreover, patients often struggle to adhere to treatment plans at home, leading to ineffective outcomes and increased healthcare costs. There is a strong need for more objective and accurate diagnostics methods, as well as for more accessible monitoring and treatment approaches, personalized for patients’ unique needs, assuring that treatment is effective. Eyecuracy provides a hybrid healthcare platform for diagnostics, monitoring, and treatment of neurological and ophthalmological disorders. It features a user-friendly hardware device, smart cloud service, and proprietary, powerful AI algorithms. Its underlying deep AI technology enables a differentiated state-of-the-art eye tracking, disease analysis and patient interaction.